Benefit–Risk Assessment via Case Studies

The development and implementation of benefit–risk assessment is multi-faceted and should be done throughout the clinical development life cycle. In this chapter, we describe five real examples that regulatory agencies considered in benefit–risk evaluations, resulting in different outcomes in their approval and marketing status. These case studies illustrate a few key considerations for a full benefit–risk evaluation.